Gene Query: SPINT1

Dataset Description Geneva Score
SUV420H2 knockdown in PANC-1 218.97
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 145.52
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 134.47
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 131.39
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 95.08
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 75.75
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 75.75
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 74.19
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 72.19
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 72.19
The role of FAM46C in myeloma cells [sequencing] 68.95
The role of FAM46C in myeloma cells 68.95
Paxillin regulates genomic networks in prostate cancer [PC3] 65.66
Diverse Compounds from Pleuromutilin Lead to a Thioredoxin Inhibitor and Inducer of Ferroptosis 63.39
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 59.13
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 58.6
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 57.59
Maturation of human iNSCs 55.99
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 55.75
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 54.74
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 54.12
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 52.8
FOXD3 is a novel tumor suppressor in lung cancer 52.71
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 49.54
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 49.51
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 49.14
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 48.3
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 47.3
Metastasis in triple negative breast cancer is dependent on ΔNp63/CXCL2/CCL22-mediated recruitment of myeloid-derived suppressor cells 46.27
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 45.39
WRN knockout effects upon gene expression in SW48 and OVK18 41.91
Endometrial epithelial cell transcriptome response to co-culture with adipose stromal cells 40.55
Discovering the anti-cancer potential of non-oncology drugs by systematic PRISM profiling 40.11
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 40.01
Generation of KRAS signatures using immortalized isogenic lung cells. 39.02
Transcriptome analysis of SKI knock-out in HL60 cells 37.77
Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1 37.77
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 36.75
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 36.64
Fbxo32 mediated gene expression program underlies EMT and metastasis 36.46
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 36.21
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 36.21
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 35.33
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 35.28
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 34.86
RNA-seq of human aneuploid cell lines with Trisomy 21 34.44
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 34.12
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 34.03
Overexpression and knockdown experiment for circCSNK1G3 33.67
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 33.44
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 32.35
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 32.34
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 32.34
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 31.41
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 31.37
Human induced pluripotent stem cell-derived vocal fold mucosa mimics development and responses to smoke exposure 31.22
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 30.46
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 30.46
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 30.39
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 30.06
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 30.06
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 29.14
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 29.14
snRNAs as regulators of alternative splicing 28.94
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 27.95
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival [RNA-Seq] 27.66
Spontaneous single-copy loss of TP53 in human embryonic stem cells markedly increases cell proliferation and survival 27.66
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 27.61
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 26.98
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 26.98
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 26.83
RNA-Seq from early time points in the kidney differentiation protocol 26.77
RNA-seq of MCF10A cells and CAF 26.69
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 26.61
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 26.61
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 26.53
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 26.51
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 26.46
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 26.39
RNA-seq Transcriptome Analysis of AD169 and AD169-ΔUL26 infected MRC5 fibroblasts. 26.22
Differential responses by human respiratory epithelial cell lines to respiratory syncytial virus reflect distinct patterns of infection control 26.01
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 25.69
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 25.57
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 25.48
Gene expression profile in breast cancer cell lines using RNA sequencing 25.48
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 25.12
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 25.12
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 25.02
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 24.18
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 24.18
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 24.09
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 23.98
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 23.62
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 23.39
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 23.15
Bulk RNA-sequencing of cell types isolated by FACS from normal human prostates 23.12
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 22.9
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 22.76
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 22.68
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 22.68
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 21.77
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 21.74
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 21.74
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 21.66
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 21.46
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 21.33
High-efficiency RNA-based reprogramming of human primary fibroblasts 21.24
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 21.22
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 21.05
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 21.05
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 21.02
Generation and functional characterization of MDSC-like cells 20.92
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 20.82
Effect of BMP inhibition or stimulation of primary human keratinocytes 20.62
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 20.62
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 20.55
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 20.53
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 19.97
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 19.97
Differentially expressed vascular development genes for iPSC-ECs from CDI 19.97
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 19.89
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 19.88
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 19.83
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 19.69
A transcriptome dataset revealing the molecular features of breast cancer stem cells 19.62
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 19.47
Transcriptomic and gene ontology profiling of the human corneal cell types 19.4
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 19.1
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 18.85
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 18.81
RNA-Seq of Kaposi’s sarcoma reveal alterations in glucose and lipid metabolism 18.6
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 18.52
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 18.52
mRNA sequencing of the global effect of SOX2 on gene expression in hESC and hESC derived NPCs. 18.46
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 18.35
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 18.28
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 18.28
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 18.18
An in vitro human liver model by iPSC-derived parenchymal and non-parenchymal cells 18.06
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 18.04
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 18.0
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 17.93
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 17.85
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 17.84
Dermal fibroblasts play a central role in skin model protection against C. albicans invasion 17.76
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 17.67
Reassessment of Exosome Composition 17.65
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 17.64
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 17.5
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 17.48
RNA-seq analysis of RALD iPSCs after in vitro differentiation 17.24
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 16.98
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 16.89
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 16.89
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 16.71
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 16.71
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 16.68
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 16.68
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 16.57
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 16.56
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 16.53
Postnatal lipids drive hepatocyte maturation 16.22
Gene expression patterns define the hepatocyte-like cells derived by different strategies 16.05
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 16.05
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 15.97
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 15.94
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 15.94
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 15.9
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 15.9
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 15.77
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of human mesenchymal stem cells differentiation from human embryonic stem cells and adult bone marrow mesenchymal stem cells 15.68
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 15.65
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 15.63
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 15.59
Expression profile of LNCaP/AR cells with or without HNF4G expression grown for long term in charcoal stripped-serum (CSS) media 15.51
Dynamic reorganization of nuclear architecture during human cardiogenesis 15.42
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 15.42
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 15.36
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 15.34
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 15.32
Generation of targeted homozygosity in the genome of human induced pluripotent stem cells 15.26
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver 15.26
Whole genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver [RNA-Seq] 15.26
Modulation of Indoleamine 2, 3-dioxygenase 1 Expression by Activated Human T cells in Breast Cancer Cells is Controlled by DNA Promoter Methylation 15.24
The acetyllysine reader BRD3R promotes human nuclear reprogramming and regulates mitosis 15.23
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 15.02
ARID1A and ARID1B loss in HCT116 cells 14.97
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 14.94
circRNA profile in hypopharyngeal cancer 14.94
ARID1A regulates condensin II distribution and chromosomal partition 14.87
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 14.87
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 14.75
RNA sequencing based comparative analysis of human hepatic progenitor cells and their niche from alcoholic steatohepatitis livers 14.72
Analysis Of The TGFb-Induced Program In Primary Airway Epithelial Cells Shows Essential Role Of NF-kB/RelA Signaling Network In Type II Epithelial Mesenchymal Transition 14.64
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 14.61
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 14.6
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 14.58
ZNF131 suppresses centrosome fragmentation in Glioblastoma stem-like cells through regulation of HAUS5 14.58
CSL 14.57
CSL RNA-Seq on HKC and SCC cell lines 14.57
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 14.49
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 14.44
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 14.42
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 14.4
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 14.29
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 14.2
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 14.2
Characterization of parental and rociletinib-resistant derived H1975 cell lines 14.19
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 14.19
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 13.94
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 13.8
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 13.74
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 13.72
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 13.72
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 13.72
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression [RNA-Seq] 13.65
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 13.61
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 13.54
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 13.43
Transcriptome of EBV-infected gastric cancer cell lines 13.4
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 13.21
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 13.16
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 13.14
Gene profiling of human adult and pediatric liver cancer cells 13.13
Gene expression analysis of BRD4 knockdown in HT-29 and HCT116 cells 13.09
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 13.0
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 12.86
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 12.82
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 12.69
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 12.69
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 12.66
Next Generation Sequencing Analysis of human embryonic stem cells derived MESP1-mTomato reporter cells 12.65
RNA-sequencing based transcriptome-wide expression profiling of Cynomolgus monkey and human IPSCs in vitro differentiated into endothelial cells 12.54
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 12.48
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 12.45
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 12.44
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 12.41
yylncT acts as a gatekeeper of the mesodermal transcriptional program by local modulation of DNMT3B [human_2] 12.25
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 12.24
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 12.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 12.23
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 12.23
Gene expression profile in response to HIF-1α inhibition together with PPARα activation and the postnatal factors (T3, IGF-1 and dexamethasone) in hiPSC-CMs 12.21
Genome-wide Analysis of Chromatin Interactions in Human Cells 12.01
Cajal bodies are linked to genome conformation [RNA-Seq] 11.95
Cajal bodies are linked to genome conformation 11.95
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 11.93
Human Hepatocytes with Drug Metabolic Function Induced from Fibroblasts by Lineage Reprogramming 11.89
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 11.85
RNA-seq differential expression studies: more sequence, or more replication? 11.75
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 11.74
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 11.72
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 11.72
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 11.64
Transcriptomic analysis of cultured corneal endothelial cells as a validation for their use in cell-replacement therapy 11.57
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 11.52
RNA-Seq analysis of primary human keratinocytes exposed to Cannabidiol 11.5
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 11.49
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 11.48
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 11.37
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 11.37
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells [RNA-seq] 11.36
Culture-induced recurrent epigenetic aberrations in human pluripotent stem cells 11.36
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 11.16
Lineage specific differentiation is influenced by state of human pluripotency 11.16
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 11.14
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 11.07
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 11.01
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 10.9
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 10.89
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 10.88
Regulation of highly expressed hCINAP on translatome 10.65
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 10.62
RNA-seq analysis of AML cells in response to ASLAN003 10.54
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 10.42
RNA-seq of cancer cell lines treated with T-025 10.34
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 10.33
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 10.31
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 10.28
RNA-seq analysis of the human fetal kidney. 10.28
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 10.25
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 10.23
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 10.23
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  10.2
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 10.17
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 10.16
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 10.16
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 10.14
Differential Protein Occupancy Profiling of the mRNA Transcriptome 10.13
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 10.08
T47D RNA-seq and ChrRNA-seq data 10.03
Arginine citrullination at the C-terminal domain controls RNA Polymerase II transcription 10.03
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 9.99
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 9.86
PANCR, the PITX2 adjacent noncoding RNA, is specifically expressed in human left atria and regulates PITX2c expression 9.81
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 9.78
Cerebellar differentiation in Ataxia-Telangiectasia 9.68
Transcriptomic analysis of iPSC and ESC challenged with atmospheric or physiological oxygen 9.64
Expression profiles of the four human major ectodermal lineages 9.47
MicroRNA targetome analysis during HCMV infection 9.23
CDK12 inhibition in Hep3B, Huh7 and SNU449 cells 9.18
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 9.11
Landscape of Hematopoiesis Described in Induced Pluripotent Stem Cells and Human Bone Marrow 9.1
RNA-Seq profiling of iPSC-derived ventricular and atrial cardiomyocytes 9.06
RNA-seq of human iPS derived macrophages with or without KLF1- transcription factor Activation 9.04
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 8.93
RNA-seq of YB5 cells treated with Proscillaridin A 8.88
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 8.71
Conservative alteration of chromosomal expression pattern across human solid tumor types 8.63
DECIDUALIZATION INDUCES A SECRETOME SWITCH IN THE PERIVASCULAR NICHE CELLS OF THE HUMAN ENDOMETRIUM 8.62
Transcriptome profiling of 5 human adenocarcinoma cell lines 8.59
Gene expression changes upon drug withdrawal (Mel888 cell line) 8.55
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 8.48
Reprogrammed myeloid cell transcriptomes in NSCLC 8.29
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 8.16
FGF2 regulation of gene expression in stable inducible Neurons 8.11
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 8.1
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization [RNA-Seq] 8.09
Transcriptional Profiling Identifies Novel Regulators of Macrophage Polarization 8.09
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 8.0
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes 7.91
Genomic and proteomic resolution of heterochromatin and its restriction of alternate fate genes (RNA-seq) 7.91
Long noncoding RNA LNMAT1 promotes lymphatic metastasis in bladder cancer 7.82
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 7.79
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 7.67
An siRNA screen identifies CHD4 as a target for epigenetic therapy 7.59
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 7.53
AMPK signaling for naïve pluripotency [Hs] 7.53
AMPK signaling for naïve pluripotency 7.53
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 7.52
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 7.48
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 7.4
Integrative analysis of mRNA and lncRNA profiles identified pathogenetic lncRNAs in esophageal squamous cell carcinoma 7.39
Fusion discovery in breast cancer cell line 7.37
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 7.34
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 7.32
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 7.29
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer 7.28
LSD1 mediates AKT activity in PIK3CA mutant colorectal cancer [RNA-Seq] 7.28
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 7.23
Gene expression profiles of BxPC-3, MiaPaCa-2 and PANC-1 cell lines treated with DMSO and THZ1 respectively 7.19
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 7.06
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 7.01
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 7.01
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 7.0
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 6.98
Transcriptome analysis of kidney organoids 6.97
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 6.96
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 6.88
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 6.84
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 6.83
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 6.79
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 6.78
RNA-seq analysis of gene expression patterns during hESC neural differentiation 6.63
hESC neural differentiation 6.63
Transcriptome analysis of human reninomas as an approach to understanding juxtaglomerular cell biology 6.56
Ro60-knockout cells 6.49
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells (2) 6.47
Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells 6.47
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 6.45
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.36
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 6.36
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 6.31
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 6.31
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 6.22
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 6.22
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 6.18
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 6.15
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 6.11
Expression by CD133+ cells isolated from the adult human exocrine pancreas 6.09
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 6.09
Direct Isolation and Characterization of Human Nephron Progenitors. 6.03
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 5.96
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 5.96
NAPRT activation of macrophages 5.85
Engineering Patient-Specific Tissue Implants 5.84
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 5.76
Next Generation Sequencing identifying the dosage compensation state in human endometrial carcinoma and adjacent tissues 5.75
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 5.6
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.48
circNFIB suppresses lymphatic metastasis of pancreatic cancer 5.42
Finding missing proteins from epigenetically manipulated human cells 5.29
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 5.23
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 5.2
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 5.19
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.19
Effect of SF3B1 suppression in cancer cells with different SF3B1 copy-number levels 5.18
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 5.08
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 4.91
Transciptomic profiling of human fetal lung samples 4.89
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 4.87
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 4.84
Identification of differentially expressed circRNA in gallbladder cancer compared with matched normal tissue 4.83
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 4.76
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 4.73
4.58
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 4.57
Expression profiling of converted and control dermal BJ fibroblasts 4.54
p63 establishes epithelial enhancers de novo at critical craniofacial development genes 4.54
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 4.43
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 4.37
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 4.28
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 4.18
ARID1A and ARID1B loss in HCT116 and TOV21G cells 4.18
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 4.07
Gene expression analysis of human liver progenitor-like cells in culture 4.04
Hydroxychloroquine inhibits responses to group A streptococcus in peripheral blood mononuclear cells 3.96
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (BGI12 RNA-Seq) 3.86
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.8
Loss of endometrial plasticity in recurrent pregnancy loss (RNA-Seq) 3.79
Loss of endometrial plasticity in recurrent pregnancy loss 3.79
Genome wide impact of loss of mechanoluminal stimulation on neonatal intestine 3.79
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 3.66
RNA sequencing quantitative analysis of RNA editing levels in ADAR1, ADAR2, AIMP2 overexpression and wild type HEK293 cells 3.62
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 3.61
Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq 3.53
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 3.49
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 3.49
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 3.45
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 3.33
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 3.33
Divergent expression and metabolic functions of human glucuronosyltransferases through alternative splicing 3.31
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 3.3
Changes in human endometrial gland transcriptome over the window of implantation 3.23
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 3.16
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.09
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.09
Transcriptional effect of ETV1 knockdown in melanoma cells 3.05
Dissecting neural differentiation regulatory networks through epigenetic footprinting 3.03
MCF10A H-Ras RNA-Seq 3.01
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 2.98
The gene expression profiles of gallbladder cancer 2.91
A map of gene expression in neutrophil-like cell lines 2.91
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 2.9
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 2.9
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 2.89
Neutrophils RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 2.82
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 2.78
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 2.69
The SS18-SSX fusion oncoprotein hijacks BAF complex targeting and function to drive synovial sarcoma [RNA-Seq Tumor] 2.65
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.65
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 2.46
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.46
Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia 2.4
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.4
Epigenetic and transcriptional analysis of mesoderm progenitor cells identifies HOPX as a novel regulator of hemogenic endothelium 2.36
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 2.35
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.28
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.16
Human Induced Pluripotent Stem Cells Recapitulate Breast Cancer Patients’ Predilection to Doxorubicin-Induced Cardiotoxicity 2.12
Characterization of EZH2-deficient human embryonic stem cells [ChIP-seq and bulk RNA-seq] 2.11
RNA splicing alteration on glioblastoma and normal neural stem cells 2.11
Glucose inhibits cardiac maturation through nucleotide biosynthesis 2.08
The expression profiles of GBC liver metastasis 2.02
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 2.0
Quantitative profiling of the UGT transcriptome in human drug metabolizing tissues [Total RNA] 1.8
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 1.8
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 1.8
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.76
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 1.66
Next Generation Sequencing of human SMA and healthy control Motor Neurons 1.54
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.53
mRNA sequencing of oropharyngeal cancer cell lines 1.47
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.38
RNA-Seq of Breast and Ovarian Cancer Cell Lines 1.35
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 1.35
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.26
Trascriptome of thyroid cancer-induced macrophages 1.2
Genome-wide identification of cancer-specific alternative splicing in circRNA 1.14
RNA-seq of IL-4 stimulated human keratinocytes 1.11
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 1.05
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 1.05
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 1.03
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 0.98
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 0.95
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 0.94
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 0.94
Macrophages redirect phagocytosis by non-professional phagocytes and influence inflammation 0.91
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.83
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.81
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.78
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.78
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.68
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.68
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 0.66
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.56
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.47
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.38
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.34
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 0.33
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.22
Ribosomal protein RPL26 is the principal target of UFMylation 0.18
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 0.16
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 0.16
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 0.13
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 0.1
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.08
Gene expression analysis of breast cancer cell-lines 0.06
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.06
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation